Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy	COVID-19, Coronaviridae Infections, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, Neurologic Manifestations, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, follicular lymphoma, immune system disorder, immunoproliferative disorder, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 3	2025-04-10		NCT04904536

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese University of Hong Kong	480
Clinica Alemana de Santiago	7
Monash University	75
The Alfred	22
The George Institute	22
Universidad del Desarrollo	8
University of Sydney	73

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The George Institute for Global Health	Sydney	Australia	1